Stay Informed on Key Developments

Investor News and Updates

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

241 - 250of 392 News

March 27, 2020

Coronavirus pandemic:

Bayer planning to hold online-only stockholders’ meeting on April 28, 2020

March 24, 2020

Bayer’s due diligence procedures for M& transactions are appropriate, special audit confirms

March 20, 2020

Not intended for U.S. and UK Media - American College of Cardiology’s 69th Annual Scientific Session together with World Congress of Cardiology (ACC.20/WCC Virtual):

Bayer announces five late-breaking presentations which include data from VICTORIA (vericiguat) and VOYAGER PAD (Xarelto™) Phase III studies

February 27, 2020

Fiscal 2019:

Bayer strategically and operationally successful

February 27, 2020

Bayer reaches agreement with stockholder Prof. Strenger on voluntary special audit of due diligence procedures

February 26, 2020

Personnel changes after Annual Stockholders' Meeting on April 28, 2020:

Norbert Winkeljohann to succeed Werner Wenning as Chairman of Bayer’s Supervisory Board